Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 4Bio Ventures, A2A, Abbvie, AGC, Alivamab Discovery, Arbor, Astrazeneca, Avita Medical, Black Cat, Cresco, CSL, Delta 4, East China Normal University, Eleva, Epivax, Exeltis Healthcare, Global Institute of Stem Cell Therapy and Research, Harbour Biomed, Healios, Heat Biologics, Ibio, Immunoprecise Antibodies, Integrated, Intravacc, Kyowa Kirin, Laxai Life Sciences, Lupin, Macure, Memo, Mitsubishi Tanabe, Modular, Novavax, Octapharma, Oncolytika, Pharmabcine, Rottapharm, Sorrento, Swift, Takis, Valirx, Vitro Diagnostics.